METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Clinical trials for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep advanced lung cancer in check
Disease control Recruiting nowThis study is testing whether adding the drug cabozantinib to pembrolizumab can help control advanced squamous non-small cell lung cancer for longer. It is for patients whose cancer has not worsened after an initial 4-cycle treatment. The main goal is to see how long patients can…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Virus therapy tested to fight lung cancer that stops responding to treatment
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer that has started to grow again after their first treatment with immunotherapy and chemotherapy. It compares a new two-part treatment—first a specially engineered virus given by IV, followed by standard chemotherapy…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC